Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Study of the effectiveness of Auditory integration therapy in the treatment of auditory hypersensitivity in autism spectrum disorders
ISRCTN ISRCTN32927930
ClinicalTrials.gov identifier
Public title Study of the effectiveness of Auditory integration therapy in the treatment of auditory hypersensitivity in autism spectrum disorders
Scientific title The effectiveness of Auditory integration therapy in the treatment of auditory hypersensitivity in autism spectrum disorders: A single blind randomised controlled trial study
Acronym AIT Autism
Serial number at source N/A
Study hypothesis Auditory integration therapy is effective in reducing the auditory hypersensitivity in autistic children
Lay summary
Ethics approval The College of Medicine and King Khalid University Ethics Committee approved on the 27th of December 2009. (ref: E-09-065)
Study design Single centre randomised controlled interventional study
Countries of recruitment Saudi Arabia
Disease/condition/study domain Autism spectrum disorders
Participants - inclusion criteria Autism spectrum disorders with auditory sensory hypersensitivity
Participants - exclusion criteria 1. Epilepsy
2. Cerebral palsy
3. Tuberous sclerosis
Anticipated start date 01/01/2010
Anticipated end date 01/01/2012
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet (in Arabic)
Target number of participants 100
Interventions The children will be assessed as follows:
1. Physician (to confirm the diagnosis) using
1.1. The Developmental, Dimensional and Diagnostic interview (3DI)
1.2. Childhood Autism Rating Scale (CARS)
2. Parents and Psychologist will fill the following
2.1. Health questionnaire
2.2. ORCA Diagnostic check list
2.3. Autism Treatment Evaluation Checklist (ATEC)
3. ENT specialist
Children with a history of seizure disorder will be excluded.
Written informed consent will be obtained from the parents/guardian.
During the study period, children were not allowed to begin any new therapies or stop any current therapies, including medications and supplements.

Auditory integration training will be conducted according to the following protocol:
The listener receives 18 to 20 listening sessions lasting for 30 minutes, over a 10- to 20-day period. In most cases, with a 1- or 2-day break after 5 days of listening. During the listening sessions, the child listens to processed music. That is, the AIT sound amplifier attenuates low and high frequencies at random from the compact discs, and then sends this modified music through headphones to the listener. This random selection of frequencies is termed 'modulation.' The intensity level (volume) during the AIT listening sessions should not exceed 85 decibels (dBA).
Primary outcome measure(s) Reflection in sensory hypersensitivity, assessed at baseline. 3, 6 and 9 months.
Secondary outcome measure(s) 1. Increased attention
2. Better hearing
3. Increased concentration
Outcomes assessed at baseline, 3, 6 and 9 months, using the following tools:
1. Parent Questionnaire
2. Health Q!uestionnaire
3. ORCA diagnositic checklist
4. CARS
5. ATEC
Sources of funding King Abdul Aziz City for Science and Technology (KACST) (Saudi Arabia)
Trial website
Publications
Contact name Prof  Laila  AL-Ayadhi
  Address Auditory Integration Therapy Project (AIT)
Professor of Neurophysiology
Consultant Diagnostic Neurophysiology
Autism Research and Treatment Centre (ART Centre) (99)
Department of physiology (29)
Faculty of Medicine
King Saud University
P O Box 2925
  City/town Riyadh
  Zip/Postcode 11461
  Country Saudi Arabia
Sponsor King Abdul Aziz City for Science and Technology (KACST) (Saudi Arabia)
  Address Riyadh
PO Box 6068
  City/town Riyadh
  Zip/Postcode 11442
  Country Saudi Arabia
  Tel +966 (0)14883555
  Fax +966 (0)14813274
  Email npst7@ksu.edu.sa
  Sponsor website: http://www.kacst.edu.sa
Date applied 24/12/2009
Last edited 31/08/2010
Date ISRCTN assigned 31/08/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central